Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 402 articles:
HTML format
Text format



Single Articles


    April 2017
  1. THAN MP, Pickering JW, Cullen L, Kavsak PA, et al
    Response by Than et al to Letter Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction".
    Circulation. 2017;135:e923-e924.
    PubMed     Text format    


  2. MUELLER C, Roffi M
    Letter by Mueller and Roffi Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction".
    Circulation. 2017;135:e921-e922.
    PubMed     Text format    


  3. IRFAN A
    Letter by Irfan Regarding Article, "Assessment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction".
    Circulation. 2017;135:e919-e920.
    PubMed     Text format    


  4. PASUPATHY S, Tavella R, Beltrame JF
    Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management.
    Circulation. 2017;135:1490-1493.
    PubMed     Text format    


  5. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
    Circulation. 2017;135:1522-1531.
    PubMed     Text format     Abstract available


  6. HERNANDEZ AF, Cruz HP
    Engagement, Research, and Evidence: Leveraging the National Patient-Centered Clinical Research Network for Better Cardiovascular Health.
    Circulation. 2017;135:1478-1480.
    PubMed     Text format    


  7. MOTOVSKA Z, Hlinomaz O, Kala P
    Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".
    Circulation. 2017;135:e887-e888.
    PubMed     Text format    


  8. LOZANO I, Rondan J, Vegas JM
    Letter by Lozano et al Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".
    Circulation. 2017;135:e885-e886.
    PubMed     Text format    


  9. KUBOTA Y, Iso H, Yamagishi K, Sawada N, et al
    Daily Total Physical Activity and Incident Cardiovascular Disease in Japanese Men and Women: Japan Public Health Center-Based Prospective Study.
    Circulation. 2017;135:1471-1473.
    PubMed     Text format    


  10. BASS TA
    Percutaneous Coronary Interventions for Chronic Total Occlusions: As the Technology Expands, Our Responsibilities Increase.
    Circulation. 2017;135:1385-1387.
    PubMed     Text format    


  11. HOFFMANN U, Ferencik M, Udelson JE, Picard MH, et al
    Prognostic Value of Noninvasive Cardiovascular Testing in Patients with Stable Chest Pain: Insights from the PROMISE Trial.
    Circulation. 2017 Apr 7. pii: CIRCULATIONAHA.116.024360.
    PubMed     Text format     Abstract available


  12. HUNTER AL, Shah AS, Langrish JP, Raftis JB, et al
    Fire Simulation and Cardiovascular Health in Firefighters.
    Circulation. 2017;135:1284-1295.
    PubMed     Text format     Abstract available


  13. AMERI K, Samurkashian R, Yeghiazarians Y
    Three-Dimensional Bioprinting: Emerging Technology in Cardiovascular Medicine.
    Circulation. 2017;135:1281-1283.
    PubMed     Text format    


    March 2017
  14. DE LEMOS JA, Ayers CR, Levine BD, deFilippi CR, et al
    A Multimodality Strategy for Cardiovascular Risk Assessment: Performance in Two Population-Based Cohorts.
    Circulation. 2017 Mar 30. pii: CIRCULATIONAHA.117.027272.
    PubMed     Text format     Abstract available


  15. AHN JM, Park DW, Shin ES, Koo BK, et al
    Fractional Flow Reserve and Cardiac Events in Coronary Artery Disease: Data From a Prospective Registry.
    Circulation. 2017 Mar 29. pii: CIRCULATIONAHA.116.024433.
    PubMed     Text format     Abstract available


  16. DAVIERWALA PM, Leontyev S
    Response by Davierwala and Leontyev to Letter Regarding Article, "Temporal Trends in Predictors of Early and Late Mortality after Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction".
    Circulation. 2017;135:e816-e817.
    PubMed     Text format    


  17. KALAVROUZIOTIS D, Dagenais F, Mohammadi S
    Letter by Kalavrouziotis et al Regarding Article, "Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction".
    Circulation. 2017;135:e814-e815.
    PubMed     Text format    



  18. Correction to: Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American C
    Circulation. 2017;135:e824-e825.
    PubMed     Text format    


  19. YANG X, Gu D
    Response by Yang and Gu to Letter Regarding Article, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)".
    Circulation. 2017;135:e822-e823.
    PubMed     Text format    


  20. KOH KK
    Letter by Koh Regarding Articles, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)" and "Distribution of Estimated 10-Year Risk of Recurrent Vascu
    Circulation. 2017;135:e818-e819.
    PubMed     Text format    


  21. FORMAN DE, Arena R, Boxer R, Dolansky MA, et al
    Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association.
    Circulation. 2017 Mar 23. pii: CIR.0000000000000483.
    PubMed     Text format     Abstract available



  22. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    PubMed     Text format    



  23. Correction to: Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Circulation. 2017;135:e788.
    PubMed     Text format    


  24. YEH RW, Kramer DB
    Decision Tools to Improve Personalized Care in Cardiovascular Disease: Moving the Art of Medicine Toward Science.
    Circulation. 2017;135:1097-1100.
    PubMed     Text format    


  25. BAIREY MERZ CN, Pepine CJ, Walsh MN, Fleg JL, et al
    Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.
    Circulation. 2017;135:1075-1092.
    PubMed     Text format     Abstract available


  26. TANG WH, Hazen SL
    The Gut Microbiome and Its Role in Cardiovascular Diseases.
    Circulation. 2017;135:1008-1010.
    PubMed     Text format    


  27. KHERA AV, Kathiresan S
    Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine.
    Circulation. 2017;135:1005-1007.
    PubMed     Text format    


  28. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available


  29. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Wildi K, et al
    Direct Comparison of Four Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I.
    Circulation. 2017 Mar 10. pii: CIRCULATIONAHA.116.025661.
    PubMed     Text format     Abstract available


  30. WANG DD, Toledo E, Hruby A, Rosner BA, et al
    Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial.
    Circulation. 2017 Mar 9. pii: CIRCULATIONAHA.116.024261.
    PubMed     Text format     Abstract available


  31. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
    Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
    Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
    PubMed     Text format     Abstract available


  32. SMYTH A, O'Donnell M, Yusuf S
    Response by Smyth et al to Letters Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study".
    Circulation. 2017;135:e644-e645.
    PubMed     Text format    


  33. SCHERFF F, Ghadri J, Templin C
    Letter by Scherff et al Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study".
    Circulation. 2017;135:e642-e643.
    PubMed     Text format    


  34. CULIC V
    Letter by Culic Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study".
    Circulation. 2017;135:e640-e641.
    PubMed     Text format    


  35. MADDOX TM, Albert NM, Borden WB, Curtis LH, et al
    The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Mar 2. pii: CIR.0000000000000480.
    PubMed     Text format     Abstract available


  36. WALDO SW, McCabe JM, Kennedy KF, Zigler CM, et al
    Quality of Care at Hospitals Identified as Outliers in Publicly Reported Mortality Statistics for Percutaneous Coronary Intervention.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.025998.
    PubMed     Text format     Abstract available


    February 2017
  37. CAVENDER MA, White WB, Jarolim P, Bakris GL, et al
    Serial Measurement of High Sensitivity Troponin I and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus in the EXAMINE Trial.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024632.
    PubMed     Text format     Abstract available


  38. MENEVEAU N, Ecarnot F
    Response by Meneveau and Ecarnot to Letter Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOC
    Circulation. 2017;135:e142-e143.
    PubMed     Text format    


  39. VALLURUPALLI S, Uretsky BF
    Letter by Vallurupalli and Uretsky Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Stu
    Circulation. 2017;135:e140-e141.
    PubMed     Text format    


  40. NADIR MA
    Letter by Nadir Regarding Article, "Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients With Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Co
    Circulation. 2017;135:e138-e139.
    PubMed     Text format    


  41. GERSH BJ, Stone GW, Bhatt DL
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence?
    Circulation. 2017;135:819-821.
    PubMed     Text format    


  42. STEFANESCU SCHMIDT AC, Kereiakes DJ, Cutlip DE, Yeh RW, et al
    Myocardial Infarction Risk after Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study.
    Circulation. 2017 Feb 22. pii: CIRCULATIONAHA.116.024835.
    PubMed     Text format     Abstract available


  43. SMOLDEREN KG, Buchanan DM, Gosch K, Whooley MA, et al
    Depression Treatment and 1-Year Mortality Following Acute Myocardial Infarction: Insights from the TRIUMPH Registry.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.025140.
    PubMed     Text format     Abstract available


  44. ATKINSON TM, Giraud GD, Togioka BM, Jones DB, et al
    Cardiovascular and Ventilatory Consequences of Laparoscopic Surgery.
    Circulation. 2017;135:700-710.
    PubMed     Text format     Abstract available


  45. HERNAEZ A, Castaner O, Elosua R, Pinto X, et al
    Mediterranean Diet Improves High-Density Lipoprotein Function in High-Cardiovascular-Risk Individuals: A Randomized Controlled Trial.
    Circulation. 2017;135:633-643.
    PubMed     Text format     Abstract available


  46. LINDAHL B, Baron T, Erlinge D, Hadziosmanovic N, et al
    Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery (MINOCA) Disease.
    Circulation. 2017 Feb 8. pii: CIRCULATIONAHA.116.026336.
    PubMed     Text format     Abstract available


  47. CHOO EH, Lee JH, Park EH, Park HE, et al
    Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Treg and Macrophage Polarization.
    Circulation. 2017 Feb 7. pii: CIRCULATIONAHA.116.023106.
    PubMed     Text format     Abstract available


  48. HESS CN, Kaltenbach LA, Doll JA, Cohen DJ, et al
    Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization.
    Circulation. 2017;135:532-543.
    PubMed     Text format     Abstract available


  49. DREYER RP, Dharmarajan K, Kennedy KF, Jones PG, et al
    Sex Differences in 1-Year All-Cause Rehospitalization in Patients After Acute Myocardial Infarction: A Prospective Observational Study.
    Circulation. 2017;135:521-531.
    PubMed     Text format     Abstract available


  50. RAMIREZ FD, Motazedian P, Jung RG, Di Santo P, et al
    Sex Bias Is Increasingly Prevalent in Preclinical Cardiovascular Research: Implications for Translational Medicine and Health Equity for Women: A Systematic Assessment of Leading Cardiovascular Journals Over a 10-Year Period.
    Circulation. 2017;135:625-626.
    PubMed     Text format    


  51. SANGHAVI M, Parikh NI
    Harnessing the Power of Pregnancy and Pregnancy-Related Events to Predict Cardiovascular Disease in Women.
    Circulation. 2017;135:590-592.
    PubMed     Text format    


  52. TANZ LJ, Stuart JJ, Williams PL, Rimm EB, et al
    Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women.
    Circulation. 2017;135:578-589.
    PubMed     Text format     Abstract available


  53. DE KAT AC, Verschuren WM, Eijkemans MJ, Broekmans FJ, et al
    Anti-Mullerian Hormone Trajectories Are Associated With Cardiovascular Disease in Women: Results From the Doetinchem Cohort Study.
    Circulation. 2017;135:556-565.
    PubMed     Text format     Abstract available


  54. PATEL A, Rutherford JD
    Improving Cardiovascular Health in Diverse Populations: A Conversation With Anushka Patel, MBBS, SM, PhD.
    Circulation. 2017;135:502-505.
    PubMed     Text format     Abstract available


  55. POLONSKY TS, Greenland P
    Breast Arterial Calcification: Expanding the Reach of Cardiovascular Prevention.
    Circulation. 2017;135:499-501.
    PubMed     Text format    


  56. GULATI M
    Improving the Cardiovascular Health of Women in the Nation: Moving Beyond the Bikini Boundaries.
    Circulation. 2017;135:495-498.
    PubMed     Text format    


  57. HAO H, Hu S, Chen H, Bu D, et al
    Loss of Endothelial CXCR7 Impairs Vascular Homeostasis, and Cardiac Remodeling After Myocardial Infarction: Implications for Cardiovascular Drug Discovery.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.023027.
    PubMed     Text format     Abstract available


  58. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    PubMed     Text format     Abstract available


    January 2017
  59. PARIKH VN, Ashley EA
    Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine.
    Circulation. 2017;135:406-409.
    PubMed     Text format    


  60. MADDOX TM, Ho PM
    Health Services Research in Improving the Delivery of Care for Patients with Cardiovascular Diseases: Moving From Observation to Innovation to Action.
    Circulation. 2017;135:403-405.
    PubMed     Text format    


  61. YANG P, Read C, Kuc RE, Buonincontri G, et al
    Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension.
    Circulation. 2017 Jan 30. pii: CIRCULATIONAHA.116.023218.
    PubMed     Text format     Abstract available


  62. ST-ONGE MP, Ard J, Baskin ML, Chiuve SE, et al
    Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Jan 30. pii: CIR.0000000000000476.
    PubMed     Text format     Abstract available


  63. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    PubMed     Text format    


  64. HEYDARI B, Harris WS, Kwong RY
    Response by Heydari et al to Letter Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Circulation. 2017;135:e13-e14.
    PubMed     Text format    


  65. NAGELE MP
    Letter by Nagele Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Circulation. 2017;135:e11-e12.
    PubMed     Text format    


  66. KOH KK
    Letter by Koh Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial".
    Circulation. 2017;135:e9-e10.
    PubMed     Text format    


  67. KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
    Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
    PubMed     Text format     Abstract available


  68. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Text format     Abstract available


  69. ALEXANDER KP
    Putting the Acute Coronary Syndrome in Context After 80 Years of Age.
    Circulation. 2017;135:5-6.
    PubMed     Text format    


    December 2016
  70. CHAPMAN AR, Anand A, Boeddinghaus J, Ferry AV, et al
    Comparison of the Efficacy and Safety of Early Rule Out Pathways for Acute Myocardial Infarction.
    Circulation. 2016 Dec 29. pii: CIRCULATIONAHA.116.025021.
    PubMed     Text format     Abstract available


  71. SCHWAMM LH, Chumbler N, Brown E, Fonarow GC, et al
    Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Circulation. 2016 Dec 20. pii: CIR.0000000000000475.
    PubMed     Text format     Abstract available


  72. STEBLOVNIK K, Blinc A, Mijovski MB, Fister M, et al
    Ticagrelor Versus Clopidogrel in Comatose Survivors of Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention and Hypothermia: A Randomized Study.
    Circulation. 2016;134:2128-2130.
    PubMed     Text format    


  73. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    PubMed     Text format     Abstract available


  74. KOH KK
    Letter by Koh Regarding Article, "Randomized Trials to Evaluate Cardiovascular Safety of Antihyperglycemic Medications: A Worthwhile Effort?"
    Circulation. 2016;134:e650-e651.
    PubMed     Text format    


  75. WILSON PW, Pencina MJ
    Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward.
    Circulation. 2016;134:1792-1793.
    PubMed     Text format    


    November 2016
  76. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    PubMed     Text format     Abstract available


  77. HOUSER SR
    The American Heart Association's New Institute for Precision Cardiovascular Medicine.
    Circulation. 2016 Nov 22. pii: CIRCULATIONAHA.116.022138.
    PubMed     Text format     Abstract available


  78. HAMPTON T
    Ongoing Research Points to Key Role of Gut Microbes in Cardiovascular Health.
    Circulation. 2016;134:1687-1688.
    PubMed     Text format    


  79. DIPROSE W, Verster F
    The Preventive-Pill Paradox: How Shared Decision Making Could Increase Cardiovascular Morbidity and Mortality.
    Circulation. 2016;134:1599-1600.
    PubMed     Text format    


  80. GAGGIN HK, Liu Y, Lyass A, van Kimmenade RR, et al
    Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.023052.
    PubMed     Text format     Abstract available


  81. POKORNEY SD, Miller AL, Chen AY, Thomas L, et al
    Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients with Low Ejection Fraction After Myocardial Infarction.
    Circulation. 2016 Nov 16. pii: CIRCULATIONAHA.116.022359.
    PubMed     Text format     Abstract available


  82. GIBSON CM, Korjian S, Tricoci P, Daaboul Y, et al
    Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025687.
    PubMed     Text format     Abstract available


  83. SHEN YC, Hsia RY
    Association Between Emergency Department Closure and Treatment, Access, and Health Outcomes Among Patients With Acute Myocardial Infarction.
    Circulation. 2016;134:1595-1597.
    PubMed     Text format    


  84. SAITO Y, Okada S, Ogawa H, Soejima H, et al
    Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025760.
    PubMed     Text format     Abstract available


  85. TOPPER JN, Rutherford JD
    Discovering and Developing Successful Cardiovascular Therapeutics: A Conversation With James N. Topper, MD, PhD.
    Circulation. 2016;134:1516-1518.
    PubMed     Text format     Abstract available


  86. TAQUETI VR, Shaw LJ, Cook NR, Murthy VL, et al
    Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography is Associated with Severely Impaired Coronary Flow Reserve, not Obstructive Disease.
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.023266.
    PubMed     Text format     Abstract available


  87. GIBSON CM, Pinto DS, Chi G, Arbetter D, et al
    Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025783.
    PubMed     Text format     Abstract available


  88. LEE SR, Prasad A, Choi YS, Xing C, et al
    The LPA Gene, Ethnicity, and Cardiovascular Events.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024611.
    PubMed     Text format     Abstract available


  89. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available


  90. BAR C, Chatterjee S, Thum T
    Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy.
    Circulation. 2016;134:1484-1499.
    PubMed     Text format     Abstract available


  91. ABBAS M, Jesel L, Auger C, Amoura LK, et al
    Endothelial Microparticles from Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cells Ageing and Thrombogenicity: Role of the Ang II/AT1 Receptor/NADPH Oxidase-mediated Activation of MAPKs and PI3-kinase Pathways.
    Circulation. 2016 Nov 7. pii: CIRCULATIONAHA.116.017513.
    PubMed     Text format     Abstract available


  92. LYNGBAKKEN MN, Skranes JB, de Lemos JA, Nygard S, et al
    Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023726.
    PubMed     Text format     Abstract available


  93. LLOYD-JONES DM, Huffman MD, Karmali KN, Sanghavi DM, et al
    Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardi
    Circulation. 2016 Nov 4. pii: CIR.0000000000000467.
    PubMed     Text format     Abstract available


  94. CARRICK D, Haig C, Ahmed N, Carberry J, et al
    Comparative Prognostic Utility of Indices of Microvascular Function Alone or in Combination in Patients with an Acute ST-Segment Elevation Myocardial Infarction.
    Circulation. 2016 Nov 1. pii: CIRCULATIONAHA.116.022603.
    PubMed     Text format     Abstract available


  95. BLOND K, Jensen MK, Rasmussen MG, Overvad K, et al
    Prospective Study of Bicycling and Risk of Coronary Heart Disease in Danish Men and Women.
    Circulation. 2016;134:1409-1411.
    PubMed     Text format    


  96. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Response by Alvarez-Garcia et al to Letters Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e401-e402.
    PubMed     Text format    


  97. BARANCHUK A
    Letter by Baranchuk Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e399-e400.
    PubMed     Text format    


  98. NG FS, Efimov IR
    Letter by Ng and Efimov Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e397-e398.
    PubMed     Text format    


  99. MCKELLAR SH, Fang JC
    An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure?
    Circulation. 2016;134:1325-1327.
    PubMed     Text format    


    October 2016
  100. KARAM N, Bataille S, Marijon E, Giovanetti O, et al
    Identifying Patients at Risk for Pre-Hospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study.
    Circulation. 2016 Oct 28. pii: CIRCULATIONAHA.116.022954.
    PubMed     Text format     Abstract available


  101. DAVIERWALA PM, Leontyev S, Verevkin A, Rastan AJ, et al
    Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction.
    Circulation. 2016;134:1224-1237.
    PubMed     Text format     Abstract available


  102. KURLANSKY P, Herbert M, Prince S, Mack M, et al
    Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.
    Circulation. 2016;134:1238-1246.
    PubMed     Text format     Abstract available


  103. KIRMANI BH, Holmes MV, Muir AD
    Long-Term Survival and Freedom From Reintervention After Off-Pump Coronary Artery Bypass Grafting: A Propensity-Matched Study.
    Circulation. 2016;134:1209-1220.
    PubMed     Text format     Abstract available


  104. GLINEUR D, Gaudino M, Grau J
    The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease.
    Circulation. 2016;134:1206-1208.
    PubMed     Text format    


  105. RUEL M
    Introduction to the Cardiovascular Surgery Themed Issue of Circulation.
    Circulation. 2016;134:1205.
    PubMed     Text format    


  106. RAY KK, Ginsberg HN, Davidson MH, Pordy R, et al
    Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab to Control.
    Circulation. 2016 Oct 24. pii: CIRCULATIONAHA.116.024604.
    PubMed     Text format     Abstract available


  107. FRIEDMAN DJ, Bao H, Spatz ES, Curtis JP, et al
    Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report from the National Cardiovascular Data Registry.
    Circulation. 2016 Oct 19. pii: CIRCULATIONAHA.116.022913.
    PubMed     Text format     Abstract available


  108. ALSHEHRY ZH, Mundra PA, Barlow CK, Mellett NA, et al
    Plasma Lipidomic Profiles Improve Upon Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.023233.
    PubMed     Text format     Abstract available


  109. PECHLANER R, Kiechl S, Mayr M
    Potential and Caveats of Lipidomics for Cardiovascular Disease.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.025092.
    PubMed     Text format     Abstract available


  110. SYME C, Czajkowski S, Shin J, Abrahamowicz M, et al
    Glycerophosphocholine Metabolites and Cardiovascular Disease Risk Factors in Adolescents: A Cohort Study.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.022993.
    PubMed     Text format     Abstract available



  111. Correction to: Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e366.
    PubMed     Text format    


  112. BOHM P, Kindermann W, Meyer T, Scharhag J, et al
    Response by Bohm et al to Letter Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study".
    Circulation. 2016;134:e364-e365.
    PubMed     Text format    


  113. LEISCHIK R, Sanchis-Gomar F, Lucia A
    Letter by Leischik et al Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study".
    Circulation. 2016;134:e362-e363.
    PubMed     Text format    


  114. HEIDBUCHEL H, Claessen G, La Gerche A
    Letter by Heidbuchel et al Regarding Article, "Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study".
    Circulation. 2016;134:e360-e361.
    PubMed     Text format    


  115. PICKERING JW, Greenslade JH, Cullen L, Flaws D, et al
    Assessment of the European Society of Cardiology 0 Hour/1 Hour Algorithm to Rule Out and Rule In Acute Myocardial Infarction.
    Circulation. 2016 Oct 17. pii: CIRCULATIONAHA.116.022677.
    PubMed     Text format     Abstract available


  116. JAFFE AS, White HD
    Ruling In Myocardial Injury and Ruling Out Myocardial Infarction With the European Society of Cardiology (ESC) 1-Hour Algorithm.
    Circulation. 2016 Oct 17. pii: CIRCULATIONAHA.116.024687.
    PubMed     Text format     Abstract available


  117. WIGGINS BS, Saseen JJ, Page RL 2nd, Reed BN, et al
    Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 17. pii: CIR.0000000000000456.
    PubMed     Text format    


  118. CAPODANNO D, Angiolillo DJ
    Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus.
    Circulation. 2016 Oct 11. pii: CIRCULATIONAHA.116.023164.
    PubMed     Text format     Abstract available


  119. SMYTH A, O'Donnell M, Lamelas P, Teo K, et al
    Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study.
    Circulation. 2016;134:1059-1067.
    PubMed     Text format     Abstract available


  120. BAGAI A, Bhatt DL, Verma S, Mehta SR, et al
    Response by Bagai et al to Letter Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".
    Circulation. 2016;134:e334-e335.
    PubMed     Text format    


  121. PETRIE CJ
    Letter by Petrie Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention".
    Circulation. 2016;134:e332-e333.
    PubMed     Text format    


  122. WIRTZ VJ, Kaplan WA, Kwan GF, Laing RO, et al
    Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries".
    Circulation. 2016;134:e305-e306.
    PubMed     Text format    


  123. ANTIGNAC M, Marijon E, Jouven X
    Letter by Antignac et al Regarding Article "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries".
    Circulation. 2016;134:e303-e304.
    PubMed     Text format    


  124. HAMPTON T
    Energy Drinks Pose Worrisome Risks to Adolescents' Cardiovascular Health.
    Circulation. 2016;134:1052-1053.
    PubMed     Text format    


    September 2016
  125. SEIDELMANN SB, Claggett B, Bravo PE, Gupta A, et al
    Retinal Vessel Calibers in Predicting Long-term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.023425.
    PubMed     Text format     Abstract available


  126. YANG X, Li J, Hu D, Chen J, et al
    Predicting the Ten-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.022367.
    PubMed     Text format     Abstract available


  127. KOH KK
    Letter by Koh Regarding Article, "Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study".
    Circulation. 2016;134:e294-5.
    PubMed     Text format    


  128. VAN DEN BERG VJ, Umans VA, Stam F, de Mulder M, et al
    Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome.
    Circulation. 2016;134:984-6.
    PubMed     Text format    



  129. Correction to: Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension.
    Circulation. 2016;134:e260.
    PubMed     Text format    


  130. LU MT, Onuma OK, Massaro JM, D'Agostino RB Sr, et al
    Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events.
    Circulation. 2016;134:897-9.
    PubMed     Text format    


  131. MANGIACAPRA F, Panaioli E, Colaiori I, Ricottini E, et al
    Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)
    Circulation. 2016;134:835-7.
    PubMed     Text format    


  132. HAMPTON T
    Experts Ponder Whether Too Much Exercise Can Compromise Cardiovascular Health and Longevity.
    Circulation. 2016;134:833-4.
    PubMed     Text format    


  133. STOREY RF, Parker WA
    Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus.
    Circulation. 2016;134:793-6.
    PubMed     Text format    


  134. LONN EM, Yusuf S
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mmHg Target?: An Antagonist View from HOPE-3.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023264.
    PubMed     Text format     Abstract available


  135. RAGHUVEER G, White DA, Hayman LL, Woo JG, et al
    Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Sep 12. pii: CIR.0000000000000443.
    PubMed     Text format     Abstract available


  136. OPARIL S, Lewis CE
    Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to < 120/80 mmHg Target?: A Protagonist View from SPRINT.
    Circulation. 2016 Sep 12. pii: CIRCULATIONAHA.116.023263.
    PubMed     Text format     Abstract available



  137. Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline
    Circulation. 2016;134:e192-4.
    PubMed     Text format    


  138. HIVERT MF, Arena R, Forman DE, Kris-Etherton PM, et al
    Medical Training to Achieve Competency in Lifestyle Counseling: An Essential Foundation for Prevention and Treatment of Cardiovascular Diseases and Other Chronic Medical Conditions: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Sep 6. pii: CIR.0000000000000442.
    PubMed     Text format    



  139. Correction to: Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/A
    Circulation. 2016;134:e195-7.
    PubMed     Text format    


  140. EVERETT BM, Hiatt WR
    Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death.
    Circulation. 2016;134:773-5.
    PubMed     Text format    


    August 2016
  141. MOTOVSKA Z, Hlinomaz O, Miklik R, Hromadka M, et al
    Prasugrel versus Ticagrelor in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study.
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024823.
    PubMed     Text format     Abstract available


  142. BONACA MP, Goto S, Bhatt DL, Steg PG, et al
    Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-T
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024637.
    PubMed     Text format     Abstract available



  143. Correction to: Part 10: Special Circumstances of Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2016;134:e122.
    PubMed     Text format    



  144. Correction to: Part 6: Pediatric Basic Life Support and Pediatric Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2016;134:e121.
    PubMed     Text format    


  145. LEMPERT LK, Yerger V, Glantz SA
    Letter by Lempert et al Regarding Article, "Menthol and Nonmenthol Cigarette Smoking: All-Cause Deaths, Cardiovascular Disease Deaths, and Other Causes of Death Among Blacks and Whites".
    Circulation. 2016;134:e119-20.
    PubMed     Text format    


  146. MOUNSEY CA, Mawhinney JA, Werner RS, Taggart DP, et al
    Does Previous Transradial Catheterization Preclude Use of the Radial Artery as a Conduit in Coronary Artery Bypass Surgery?
    Circulation. 2016;134:681-8.
    PubMed     Text format     Abstract available


  147. MASOUDI FA
    Quality Measurement and Accountability in Cardiovascular Medicine: An Incomplete Revolution.
    Circulation. 2016;134:632-4.
    PubMed     Text format    


  148. SABE MA, Sabe SA, Kusunose K, Flamm SD, et al
    Predictors and Prognostic Significance of Right Ventricular Ejection Fraction in Patients With Ischemic Cardiomyopathy.
    Circulation. 2016;134:656-65.
    PubMed     Text format     Abstract available


  149. PETRIE MC, Jhund PS, She L, Adlbrecht C, et al
    Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure)
    Circulation. 2016 Aug 29. pii: CIRCULATIONAHA.116.024800.
    PubMed     Text format     Abstract available


  150. MENEVEAU N, Souteyrand G, Motreff P, Caussin C, et al
    Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS (Does Optical Coherence Tomography Optimize Results of Ste
    Circulation. 2016 Aug 29. pii: CIRCULATIONAHA.116.024393.
    PubMed     Text format     Abstract available


  151. FRANCHI F, Rollini F, Aggarwal N, Hu J, et al
    A Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
    Circulation. 2016 Aug 24. pii: CIRCULATIONAHA.116.023402.
    PubMed     Text format     Abstract available


  152. NORBY FL, Soliman EZ, Chen LY, Bengtson LG, et al
    Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).
    Circulation. 2016;134:599-610.
    PubMed     Text format     Abstract available


  153. STEG PG, Roussel R
    Randomized Trials to Evaluate Cardiovascular Safety of Antihyperglycemic Medications: A Worthwhile Effort?
    Circulation. 2016;134:571-3.
    PubMed     Text format    


  154. SHARKEY SW, Orlandi Q, Olivari MT
    Response by Sharkey et al to Letter Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e111-2.
    PubMed     Text format    


  155. LITTMANN L
    Letter by Littmann Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e109-10.
    PubMed     Text format    


  156. ROSSELLO X, Yellon DM
    Cardioprotection: The Disconnect Between Bench and Bedside.
    Circulation. 2016;134:574-5.
    PubMed     Text format    


  157. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    PubMed     Text format     Abstract available


  158. BRAILLON A
    Letter by Braillon Regarding Article, "Resource Effective Strategies to Prevent and Treat Cardiovascular Disease".
    Circulation. 2016;134:e85-6.
    PubMed     Text format    


  159. HOLLANDER JE, Than M, Mueller C
    State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes.
    Circulation. 2016;134:547-64.
    PubMed     Text format     Abstract available


  160. WING JJ, August E, Adar SD, Dannenberg AL, et al
    Change in Neighborhood Characteristics and Change in Coronary Artery Calcium: A Longitudinal Investigation in the MESA (Multi-Ethnic Study of Atherosclerosis) Cohort.
    Circulation. 2016;134:504-13.
    PubMed     Text format     Abstract available


  161. CALIFF RM
    The US Food and Drug Administration and Cardiovascular Medicine: Reflections and Observations.
    Circulation. 2016;134:501-3.
    PubMed     Text format    


  162. KUEHN BM
    US Cardiologists Embrace Population Health.
    Circulation. 2016;134:565-6.
    PubMed     Text format    


  163. YOUNG DR, Hivert MF, Alhassan S, Camhi SM, et al
    Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association.
    Circulation. 2016 Aug 15. pii: CIR.0000000000000440.
    PubMed     Text format     Abstract available


  164. STEINBERGER J, Daniels SR, Hagberg N, Isasi CR, et al
    Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 11. pii: CIR.0000000000000441.
    PubMed     Text format     Abstract available


  165. BRAUN LT, Grady KL, Kutner JS, Adler E, et al
    Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.
    Circulation. 2016 Aug 8. pii: CIR.0000000000000438.
    PubMed     Text format     Abstract available


  166. HEYDARI B, Abdullah S, Pottala JV, Shah R, et al
    Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
    Circulation. 2016;134:378-91.
    PubMed     Text format     Abstract available


  167. JACOBS AK
    The Challenge to Implement Systems of Care for ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2016;134:375-7.
    PubMed     Text format    


  168. KIRTANE AJ, Doshi D, Leon MB, Lasala JM, et al
    Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.
    Circulation. 2016;134:422-31.
    PubMed     Text format     Abstract available


  169. JOLLIS JG, Al-Khalidi HR, Roettig ML, Berger PB, et al
    Regional Systems of Care Demonstration Project: American Heart Association Mission: Lifeline STEMI Systems Accelerator.
    Circulation. 2016;134:365-74.
    PubMed     Text format     Abstract available


  170. DOUGLAS PS
    Achieving the Full "PROMISE" of Imaging Outcomes Research.
    Circulation. 2016;134:359-61.
    PubMed     Text format    


  171. CAVENDER MA, Bhatt DL, Stone GW, White HD, et al
    Consistent Reduction in Peri-Procedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX.
    Circulation. 2016 Aug 1. pii: CIRCULATIONAHA.115.020829.
    PubMed     Text format     Abstract available


    July 2016
  172. HEERSPINK HJ, Perkins BA, Fitchett DH, Husain M, et al
    Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes: Cardiovascular and Kidney Effects, Potential Mechanisms and Clinical Applications.
    Circulation. 2016 Jul 28. pii: CIRCULATIONAHA.116.021887.
    PubMed     Text format     Abstract available


  173. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Text format     Abstract available


  174. BOHULA EA, Bonaca MP, Braunwald E, Aylward PE, et al
    Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Circulation. 2016;134:304-13.
    PubMed     Text format     Abstract available


  175. NANCHEN D, Gencer B, Muller O, Auer R, et al
    Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.116.023007.
    PubMed     Text format     Abstract available


  176. NGO D, Sinha S, Shen D, Kuhn EW, et al
    Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Circulation. 2016;134:270-85.
    PubMed     Text format     Abstract available


  177. GRAMOLINI A, Lau E, Liu PP
    Identifying Low-Abundance Biomarkers: Aptamer-Based Proteomics Potentially Enables More Sensitive Detection in Cardiovascular Diseases.
    Circulation. 2016;134:286-9.
    PubMed     Text format    


  178. TANG SY, Monslow J, R Grant G, Todd L, et al
    Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Circulation. 2016;134:328-38.
    PubMed     Text format     Abstract available


  179. MICHOS ED, Blaha MJ
    Encouraging Young Women to Move More: Linking Physical Activity in Young Adulthood to Coronary Risk in Women.
    Circulation. 2016;134:300-3.
    PubMed     Text format    


  180. ANTER E, Tschabrunn CM, Buxton AE, Josephson ME, et al
    High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit.
    Circulation. 2016;134:314-27.
    PubMed     Text format     Abstract available


  181. BITTENCOURT MS, Hulten E, Polonsky TS, Hoffman U, et al
    European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry.
    Circulation. 2016;134:201-11.
    PubMed     Text format     Abstract available


  182. DZAU VJ
    The National Academy of Medicine and the Cardiovascular Community: Partnering for a Healthier Future.
    Circulation. 2016;134:183-5.
    PubMed     Text format    


  183. ROGERS T, Steinvil A, Torguson R, Waksman R, et al
    Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the AngelMed Guardian System.
    Circulation. 2016;134:262-4.
    PubMed     Text format    


  184. KEREIAKES DJ, Onuma Y, Serruys PW, Stone GW, et al
    Bioresorbable Vascular Scaffolds for Coronary Revascularization.
    Circulation. 2016;134:168-82.
    PubMed     Text format     Abstract available


  185. SERRUYS PW, Rutherford JD
    The Birth, and Evolution, of Percutaneous Coronary Interventions: A Conversation With Patrick Serruys, MD, PhD.
    Circulation. 2016;134:97-100.
    PubMed     Text format    


  186. GRISANTI LA, Gumpert AM, Traynham CJ, Gorsky JE, et al
    Leukocyte-Expressed beta2-Adrenergic Receptors Are Essential for Survival After Acute Myocardial Injury.
    Circulation. 2016;134:153-67.
    PubMed     Text format     Abstract available


  187. RYDEN L
    Response by Ryden to Letter Regarding Article, "Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study".
    Circulation. 2016;134:e2.
    PubMed     Text format    


  188. DIZMAN N, Cakir IB, Oguz A
    Letter by Dizman et al Regarding Article, "Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study".
    Circulation. 2016;134:e1.
    PubMed     Text format    


  189. PERAK AM, Ning H, de Ferranti SD, Gooding HC, et al
    Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Circulation. 2016;134:9-19.
    PubMed     Text format     Abstract available


  190. SHAH SJ, Kitzman DW, Borlaug BA, van Heerebeek L, et al
    Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
    Circulation. 2016;134:73-90.
    PubMed     Text format     Abstract available


  191. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    PubMed     Text format    


    June 2016
  192. RUMSFELD JS, Brooks SC, Aufderheide TP, Leary M, et al
    Use of Mobile Devices, Social Media, and Crowdsourcing as Digital Strategies to Improve Emergency Cardiovascular Care: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Jun 22. pii: CIR.0000000000000428.
    PubMed     Text format    


  193. FAXON DP, Williams DO
    Interventional Cardiology: Current Status and Future Directions in Coronary Disease and Valvular Heart Disease.
    Circulation. 2016;133:2697-711.
    PubMed     Text format    


  194. BROWN DW, MacRae CA, Gardner TJ
    The Future of Cardiovascular Education and Training.
    Circulation. 2016;133:2734-42.
    PubMed     Text format    


  195. SHEMIN RJ
    The Future of Cardiovascular Surgery.
    Circulation. 2016;133:2712-5.
    PubMed     Text format    


  196. SOLOMON SD, Pfeffer MA
    The Future of Clinical Trials in Cardiovascular Medicine.
    Circulation. 2016;133:2662-70.
    PubMed     Text format    


  197. DI CARLI MF, Geva T, Davidoff R
    The Future of Cardiovascular Imaging.
    Circulation. 2016;133:2640-61.
    PubMed     Text format    


  198. VASAN RS, Benjamin EJ
    The Future of Cardiovascular Epidemiology.
    Circulation. 2016;133:2626-33.
    PubMed     Text format    


  199. LEE RT, Walsh K
    The Future of Cardiovascular Regenerative Medicine.
    Circulation. 2016;133:2618-25.
    PubMed     Text format    


  200. MACRAE CA, Roden DM, Loscalzo J
    The Future of Cardiovascular Therapeutics.
    Circulation. 2016;133:2610-7.
    PubMed     Text format    


  201. MACRAE CA, Loscalzo J
    The Future of Cardiovascular Biomedicine.
    Circulation. 2016;133:2601-2.
    PubMed     Text format    


  202. LU Y, Ezzati M, Rimm EB, Hajifathalian K, et al
    Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United States.
    Circulation. 2016 Jun 20. pii: CIRCULATIONAHA.115.018102.
    PubMed     Text format     Abstract available


  203. CARRERAS ET, Chatzizisis YS, Mauri L, MacRae C, et al
    Acute Coronary Syndrome in a 52-Year-Old Woman With Scleroderma.
    Circulation. 2016;133:2576-82.
    PubMed     Text format    


  204. KWAN GF, Mayosi BM, Mocumbi AO, Miranda JJ, et al
    Endemic Cardiovascular Diseases of the Poorest Billion.
    Circulation. 2016;133:2561-75.
    PubMed     Text format     Abstract available


  205. WU Y, Benjamin EJ, MacMahon S
    Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China.
    Circulation. 2016;133:2545-60.
    PubMed     Text format     Abstract available


  206. MENDES M
    Is There a Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting? There is No Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting.
    Circulation. 2016;133:2538-43.
    PubMed     Text format    


  207. NIEBAUER J
    Is There a Role for Cardiac Rehabilitation After Coronary Artery Bypass Grafting? Treatment After Coronary Artery Bypass Surgery Remains Incomplete Without Rehabilitation.
    Circulation. 2016;133:2529-37.
    PubMed     Text format    


  208. LOW WANG CC, Hess CN, Hiatt WR, Goldfine AB, et al
    Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.
    Circulation. 2016;133:2459-502.
    PubMed     Text format     Abstract available


  209. ZONG G, Gao A, Hu FB, Sun Q, et al
    Whole Grain Intake and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Meta-Analysis of Prospective Cohort Studies.
    Circulation. 2016;133:2370-80.
    PubMed     Text format     Abstract available


  210. MITTER SS, Vedanthan R, Islami F, Pourshams A, et al
    Household Fuel Use and Cardiovascular Disease Mortality: Golestan Cohort Study.
    Circulation. 2016;133:2360-9.
    PubMed     Text format     Abstract available


  211. SAMET JM, Bahrami H, Berhane K
    Indoor Air Pollution and Cardiovascular Disease: New Evidence From Iran.
    Circulation. 2016;133:2342-4.
    PubMed     Text format    


  212. TZOULAKI I, Elliott P, Kontis V, Ezzati M, et al
    Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects: Current Knowledge and Data Gaps.
    Circulation. 2016;133:2314-33.
    PubMed     Text format     Abstract available


    May 2016
  213. PATEL RS, Ghasemzadeh N, Eapen DJ, Sher S, et al
    Response to Letter Regarding Article "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease".
    Circulation. 2016;133:e667.
    PubMed     Text format    


  214. HOANG S, Girerd X, Giral P
    Letter by Hoang et al Regarding Article, "Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease".
    Circulation. 2016;133:e666.
    PubMed     Text format    


  215. GEWIRTZ H, Dilsizian V
    Integration of Quantitative Positron Emission Tomography Absolute Myocardial Blood Flow Measurements in the Clinical Management of Coronary Artery Disease.
    Circulation. 2016;133:2180-96.
    PubMed     Text format     Abstract available


  216. BAGAI A, Bhatt DL, Eikelboom JW, Mancini GB, et al
    Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
    Circulation. 2016;133:2094-8.
    PubMed     Text format    


  217. WIRTZ VJ, Kaplan WA, Kwan GF, Laing RO, et al
    Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.
    Circulation. 2016;133:2076-85.
    PubMed     Text format     Abstract available


  218. SCHULMAN-MARCUS J, Boden WE
    A PROMISE Fulfilled That Quality-of-Life Assessments Afford Incremental Value to Coronary Artery Disease Management.
    Circulation. 2016;133:1989-91.
    PubMed     Text format    


  219. MYERSON SG, d'Arcy J, Christiansen JP, Dobson LE, et al
    Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic Resonance Quantitation.
    Circulation. 2016 May 17. pii: CIRCULATIONAHA.115.017888.
    PubMed     Text format     Abstract available



  220. ECG Response: May 17, 2016.
    Circulation. 2016;133:1984.
    PubMed     Text format    


  221. BENSON MD, Lapedis CJ, Adler DS, Feinberg MW, et al
    Bulging at the Root: An Inflammatory Tale.
    Circulation. 2016;133:1969-77.
    PubMed     Text format    


  222. BITTENCOURT MS, Hulten EA, Veeranna V, Blankstein R, et al
    Coronary Computed Tomography Angiography in the Evaluation of Chest Pain of Suspected Cardiac Origin.
    Circulation. 2016;133:1963-8.
    PubMed     Text format    


  223. ZHANG ZM, Rautaharju PM, Prineas RJ, Rodriguez CJ, et al
    Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.
    Circulation. 2016 May 16. pii: CIRCULATIONAHA.115.021177.
    PubMed     Text format     Abstract available


  224. LEE CH, Sethi R, Li R, Ho HH, et al
    Obstructive Sleep Apnea and Cardiovascular Events After Percutaneous Coronary Intervention.
    Circulation. 2016 May 13. pii: CIRCULATIONAHA.115.019392.
    PubMed     Text format     Abstract available


  225. SACCO RL, Roth GA, Reddy KS, Arnett DK, et al
    The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Circulation. 2016 May 9. pii: CIR.0000000000000395.
    PubMed     Text format     Abstract available


  226. VITAL SA, Becker F, Holloway PM, Russell J, et al
    Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.115.020633.
    PubMed     Text format     Abstract available


  227. GULATI R, Gersh BJ
    Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction: Do We Have the Evidence?
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.116.022733.
    PubMed     Text format     Abstract available


  228. BANGALORE S, Guo Y, Samadashvili Z, Blecker S, et al
    Revascularization in Patients with Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery.
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.115.021168.
    PubMed     Text format     Abstract available


  229. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans.
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.116.021700.
    PubMed     Text format     Abstract available


  230. PLACIDO R, Martins SR, Canas da Silva P, Infante de Oliveira E, et al
    ST-Segment-Elevation Myocardial Infarction Attributable to Left Main Coronary Artery Compression.
    Circulation. 2016;133:1828-9.
    PubMed     Text format    


  231. WEINTRAUB WS, Garratt KN
    Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Not Routinely Be Treated With Coronary Artery Bypass Grafting.
    Circulation. 2016;133:1818-25.
    PubMed     Text format    


  232. ZAKKAR M, George SJ, Ascione R
    Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting? Chronic Total Occlusion Should Be Treated With Coronary Artery Bypass Grafting.
    Circulation. 2016;133:1807-16.
    PubMed     Text format    



  233. ECG Response: May 3, 2016.
    Circulation. 2016;133:1827.
    PubMed     Text format    


    April 2016
  234. MARK DB, Anstrom KJ, Sheng S, Baloch KN, et al
    Quality of Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial.
    Circulation. 2016 Apr 27. pii: CIRCULATIONAHA.115.020259.
    PubMed     Text format     Abstract available


  235. PARIKH NI, Jeppson RP, Berger JS, Eaton CB, et al
    Reproductive Risk Factors and Coronary Heart Disease in the Women's Health Initiative Observational Study.
    Circulation. 2016 Apr 19. pii: CIRCULATIONAHA.115.017854.
    PubMed     Text format     Abstract available


  236. PRABHAKARAN D, Jeemon P, Roy A
    Cardiovascular Diseases in India: Current Epidemiology and Future Directions.
    Circulation. 2016;133:1605-20.
    PubMed     Text format     Abstract available


  237. ROBINSON JG, Ray K
    Moving Toward the Next Paradigm for Cardiovascular Prevention.
    Circulation. 2016;133:1533-6.
    PubMed     Text format    


  238. WAKS JW, Sitlani CM, Soliman EZ, Kabir M, et al
    Global Electrical Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
    Circulation. 2016 Apr 14. pii: CIRCULATIONAHA.116.021306.
    PubMed     Text format     Abstract available


  239. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


  240. RICH MW, Chyun DA, Skolnick AH, Alexander KP, et al
    Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.
    Circulation. 2016 Apr 11. pii: CIR.0000000000000380.
    PubMed     Text format     Abstract available


  241. TSUDA K
    Letter by Tsuda Regarding Article, "Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors".
    Circulation. 2016;133:e590.
    PubMed     Text format    


  242. ONORATO A, Sturm AC
    Heterozygous Familial Hypercholesterolemia.
    Circulation. 2016;133:e587-9.
    PubMed     Text format    


  243. BLUMENTHAL JA, Sherwood A, Smith PJ, Watkins L, et al
    Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial.
    Circulation. 2016;133:1341-50.
    PubMed     Text format     Abstract available


    March 2016
  244. LEVINE GN, Bates ER, Bittl JA, Brindis RG, et al
    2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of
    Circulation. 2016 Mar 29. pii: CIR.0000000000000404.
    PubMed     Text format    


  245. BITTL JA, Baber U, Bradley SM, Wijeysundera DN, et al
    Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart A
    Circulation. 2016 Mar 29. pii: CIR.0000000000000405.
    PubMed     Text format    


  246. MICHOS ED, Martin SS, Blumenthal RS
    Response to the Letter Regarding Article, "Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One?".
    Circulation. 2016;133:e462.
    PubMed     Text format    


  247. ROBINSON JG
    Letter by Robinson Regarding Articles, "Bringing Back Targets to 'IMPROVE' Atherosclerotic Cardiovascular Disease Outcomes: The Duel for Dual Goals; Are Two Targets Better Than One?" and "Achievement of Dual Low-Density Lipoprotein Cholesterol and Hig
    Circulation. 2016;133:e461.
    PubMed     Text format    


  248. BOHULA EA, Giugliano RP, Cannon CP, Zhou J, et al
    Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-I
    Circulation. 2016;133:e463.
    PubMed     Text format    


  249. MUNRO HM, Tarone RE, Wang TJ, Blot WJ, et al
    Menthol and Non-Menthol Cigarette Smoking: All-Cause, Cardiovascular Disease and Other Causes of Death Among Blacks and Whites.
    Circulation. 2016 Mar 28. pii: CIRCULATIONAHA.115.020536.
    PubMed     Text format     Abstract available


  250. HAGUE WE, Simes J, Kirby A, Keech AC, et al
    Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study.
    Circulation. 2016 Mar 25. pii: CIRCULATIONAHA.115.018580.
    PubMed     Text format     Abstract available


  251. YAMAJI K, Shiomi H, Morimoto T, Nakatsuma K, et al
    Effects of Age and Sex on Clinical Outcomes after Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients with Triple Vessel Coronary Artery Disease.
    Circulation. 2016 Mar 23. pii: CIRCULATIONAHA.115.020955.
    PubMed     Text format     Abstract available


  252. HARTLEY A, Marshall DC, Salciccioli JD, Sikkel MB, et al
    Trends in Mortality from Ischaemic Heart Disease and Cerebrovascular Disease in Europe: 1980-2009.
    Circulation. 2016 Mar 22. pii: CIRCULATIONAHA.115.018931.
    PubMed     Text format     Abstract available


  253. KOVESDY CP, Norris KC, Boulware LE, Lu JL, et al
    Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".
    Circulation. 2016;133:e453.
    PubMed     Text format    


  254. KULLER LH, Neaton JD
    Letter by Kuller and Neaton Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".
    Circulation. 2016;133:e452.
    PubMed     Text format    


  255. FONTANA M, Pica S, Reant P, Abdel-Gadir A, et al
    Response to Letters Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Circulation. 2016;133:e450-1.
    PubMed     Text format    


  256. COHEN LP, Maurer MS
    Letter by Cohen and Maurer Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Circulation. 2016;133:e449.
    PubMed     Text format    


  257. AQUARO GD, Todiere G, Barison A
    Letter by Aquaro et al Regarding Article, "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis".
    Circulation. 2016;133:e448.
    PubMed     Text format    


  258. SLIWA K, Acquah L, Gersh BJ, Mocumbi AO, et al
    Impact of Socioeconomic Status, Ethnicity, and Urbanization on Risk Factor Profiles of Cardiovascular Disease in Africa.
    Circulation. 2016;133:1199-208.
    PubMed     Text format     Abstract available


  259. MEREDITH IT, Tanguay JF, Kereiakes DJ, Cutlip DE, et al
    Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
    Circulation. 2016 Mar 18. pii: CIRCULATIONAHA.115.016783.
    PubMed     Text format     Abstract available


  260. MOBIUS-WINKLER S, Uhlemann M, Adams V, Sandri M, et al
    Coronary Collateral Growth Induced by Physical Exercise: Results of the Leipzig EXerCIse Training versus MEdical Management in Patients With Stable Coronary Artery Disease (EXCITE) Trial.
    Circulation. 2016 Mar 15. pii: CIRCULATIONAHA.115.016442.
    PubMed     Text format     Abstract available


  261. GOULD KL
    Intense Exercise and Native Collateral Function in Stable Moderate Coronary Artery Disease: Incidental, Causal or Clinically Important?
    Circulation. 2016 Mar 15. pii: CIRCULATIONAHA.116.022037.
    PubMed     Text format     Abstract available


  262. SMILOWITZ NR, Berger JS
    Perioperative Management to Reduce Cardiovascular Events.
    Circulation. 2016;133:1125-30.
    PubMed     Text format    


  263. KOENE RJ, Prizment AE, Blaes A, Konety SH, et al
    Shared Risk Factors in Cardiovascular Disease and Cancer.
    Circulation. 2016;133:1104-14.
    PubMed     Text format     Abstract available


  264. HIBBS J, Orlandi Q, Olivari MT, Dickey W, et al
    Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension.
    Circulation. 2016;133:1132-4.
    PubMed     Text format    


  265. MAMAS MA, Nolan J, de Belder MA, Zaman A, et al
    Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.018083.
    PubMed     Text format     Abstract available


  266. LAIRD JR, Hong M
    Drug Eluting Stents in the SFA: The Long and Winding Road.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.116.022039.
    PubMed     Text format     Abstract available


  267. WILMOT KA, O'Flaherty M, Capewell S, Ford ES, et al
    Response to Letter Regarding Article, "Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women".
    Circulation. 2016;133:e433.
    PubMed     Text format    


  268. GUPTA A, Rajagopalan S
    Letter by Gupta and Rajagopalan Regarding Article, "Coronary Heart Disease Mortality Declines in the United States From 1979 Through 2011: Evidence for Stagnation in Young Adults, Especially Women".
    Circulation. 2016;133:e432.
    PubMed     Text format    


  269. KRAGHOLM K, Goldstein SA, Yang Q, Lopes RD, et al
    Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment Elevation Acute Coronary Syndromes Clinical Trials.
    Circulation. 2016 Mar 8. pii: CIRCULATIONAHA.115.017299.
    PubMed     Text format     Abstract available


  270. SAW J, Bezerra H, Gornik HL, Machan L, et al
    Angiographic and Intracoronary Manifestations of Coronary Fibromuscular Dysplasia.
    Circulation. 2016 Mar 8. pii: CIRCULATIONAHA.115.020282.
    PubMed     Text format     Abstract available


  271. ARSALAN M, Mack MJ
    Coronary Artery Bypass Grafting Is Currently Underutilized.
    Circulation. 2016;133:1036-45.
    PubMed     Text format    


  272. FEARON WF, Harrington RA
    Coronary Artery Bypass Surgery Is Not Underutilized!
    Circulation. 2016;133:1027-35.
    PubMed     Text format    


  273. MOSTOFSKY E, Chahal HS, Mukamal KJ, Rimm EB, et al
    Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis.
    Circulation. 2016;133:979-87.
    PubMed     Text format     Abstract available


  274. LAU ES, O'Donoghue ML, Hamilton MA, Goldhaber SZ, et al
    Women and Heart Attacks.
    Circulation. 2016;133:e428-9.
    PubMed     Text format    


  275. SANTOS-GALLEGO CG, Vahl TP, Goliasch G, Picatoste B, et al
    Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Circulation. 2016;133:954-66.
    PubMed     Text format     Abstract available


  276. BONACA MP, Gutierrez JA, Creager MA, Scirica BM, et al
    Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Inf
    Circulation. 2016;133:997-1005.
    PubMed     Text format     Abstract available


  277. THANASSOULIS G, Williams K, Kimler Altobelli K, Pencina MJ, et al
    Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
    Circulation. 2016 Mar 4. pii: CIRCULATIONAHA.115.018383.
    PubMed     Text format     Abstract available


  278. BRADLEY SM, Bohn CM, Malenka DJ, Graham MM, et al
    Response to Letter Regarding Article, "Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program".
    Circulation. 2016;133:e424.
    PubMed     Text format    


  279. INOHARA T, Kohsaka S, Fukuda K
    Letter by Inohara et al Regarding Article, "Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program".
    Circulation. 2016;133:e423.
    PubMed     Text format    


  280. MARON MS, Maron BJ
    Response to Letter Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy".
    Circulation. 2016;133:e422.
    PubMed     Text format    


  281. FERREIRA A, Marques H, Cardim N
    Letter by Ferreira et al Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy".
    Circulation. 2016;133:e421.
    PubMed     Text format    


  282. LI W, Cornell RF, Lenihan D, Slosky D, et al
    Cardiovascular Complications of Novel Multiple Myeloma Treatments.
    Circulation. 2016;133:908-12.
    PubMed     Text format    


  283. HENRI O, Pouehe C, Houssari M, Galas L, et al
    Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction.
    Circulation. 2016 Mar 1. pii: CIRCULATIONAHA.115.020143.
    PubMed     Text format     Abstract available


  284. MOCHMANN HC, Scheitz JF, Petzold GC, Haeusler KG, et al
    Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The TRoponin ELevation in Acute Ischemic Stroke (TRELAS) Study.
    Circulation. 2016 Mar 1. pii: CIRCULATIONAHA.115.018547.
    PubMed     Text format     Abstract available


    February 2016
  285. MCSWEENEY JC, Rosenfeld AG, Abel WM, Braun LT, et al
    Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Feb 29. pii: CIR.0000000000000381.
    PubMed     Text format    


  286. KULLO IJ, Jouni H, Austin EE, Brown SA, et al
    Incorporating a Genetic Risk Score into Coronary Heart Disease Risk Estimates: Effect on LDL Cholesterol Levels (the MIGENES Clinical Trial).
    Circulation. 2016 Feb 25. pii: CIRCULATIONAHA.115.020109.
    PubMed     Text format     Abstract available


  287. NATARAJAN P, O'Donnell CJ
    Reducing Cardiovascular Risk Using Genomic Information in the Era of Precision Medicine.
    Circulation. 2016 Feb 25. pii: CIRCULATIONAHA.116.021765.
    PubMed     Text format     Abstract available


  288. SHIKANY JM, Safford MM, Newby PK, Durant RW, et al
    Response to Letter Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".
    Circulation. 2016;133:e416.
    PubMed     Text format    


  289. ARCHER E
    Letter by Archer Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study".
    Circulation. 2016;133:e415.
    PubMed     Text format    


  290. SCHWALM JD, McKee M, Huffman MD, Yusuf S, et al
    Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.
    Circulation. 2016;133:742-55.
    PubMed     Text format     Abstract available


  291. ALEXANDER KM, Veillet-Chowdhury MR, MacIntyre CJ, Loscalzo J, et al
    A Shocking Development in a Young Male Athlete With Chest Pain.
    Circulation. 2016;133:756-63.
    PubMed     Text format    


  292. LEANDER K, Malarstig A, Van't Hooft FM, Hyde C, et al
    Circulating PCSK9 Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors.
    Circulation. 2016 Feb 19. pii: CIRCULATIONAHA.115.018531.
    PubMed     Text format     Abstract available


  293. ECKEL RH, Hokanson JE
    The Prediction of Atherosclerotic Cardiovascular Disease in Type 1 Diabetes: Do We Just Stop Here?
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.116.021654.
    PubMed     Text format     Abstract available


  294. VISTISEN D, Andersen GS, Hansen CS, Hulman A, et al
    Prediction of First Cardiovascular Disease Event in Type 1 Diabetes: The Steno T1 Risk Engine.
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.115.018844.
    PubMed     Text format     Abstract available


  295. LEE JM, Hwang D, Park J, Kim KJ, et al
    Response to Letter Regarding Article, "Percutaneous Coronary Intervention at Centers With and Without On-Site Surgical Backup: An Updated Meta-Analysis of 23 Studies".
    Circulation. 2016;133:e407.
    PubMed     Text format    


  296. GARG S, Anderson SG, Woodward M
    Letter by Garg et al Regarding Article, "Percutaneous Coronary Intervention at Centers With and Without On-Site Surgical Backup: An Updated Meta-Analysis of 23 Studies".
    Circulation. 2016;133:e406.
    PubMed     Text format    


  297. SUMNER JA, Kubzansky LD, Elkind MS, Roberts AL, et al
    Response to Letter Regarding Article, "Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women".
    Circulation. 2016;133:e401-2.
    PubMed     Text format    


  298. DURMAZ O, Kucuk U, Olgun Kucuk H
    Letter by Durmaz et al Regarding Article, "Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women".
    Circulation. 2016;133:e400.
    PubMed     Text format    


  299. ZHENG Z, Zhang H, Yuan X, Zhang H, et al
    Response to Letters Regarding Article, "Efficacy of Long-Term beta-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
    Circulation. 2016;133:e394-5.
    PubMed     Text format    


  300. KARDESOGLU E, Isilak Z, Yalcin M
    Letter by Kardesoglu et al Regarding Article, "Efficacy of Long-Term beta-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
    Circulation. 2016;133:e393.
    PubMed     Text format    


  301. BERGEROT C, Farhat F, Mewton N
    Letter by Bergerot et al Regarding Article, "Efficacy of Long-Term beta-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
    Circulation. 2016;133:e392.
    PubMed     Text format    


  302. POULLIS M
    Letter by Poullis Regarding Article, "Efficacy of Long-Term beta-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
    Circulation. 2016;133:e391.
    PubMed     Text format    


  303. PEARSON-STUTTARD J, Guzman Castillo M, Penalvo JL, Rehm CD, et al
    Modelling Future Cardiovascular Disease Mortality in the United States: National Trends and Racial and Ethnic Disparities.
    Circulation. 2016 Feb 4. pii: CIRCULATIONAHA.115.019904.
    PubMed     Text format     Abstract available


  304. XIANG FL, Guo M, Yutzey KE
    Overexpression of Tbx20 in Adult Cardiomyocytes Promotes Proliferation and Improves Cardiac Function After Myocardial Infarction.
    Circulation. 2016 Feb 3. pii: CIRCULATIONAHA.115.019357.
    PubMed     Text format     Abstract available


  305. NOGUCHI T, Yasuda S, Shibata T, Kawakami S, et al
    Response to Letter Regarding Article, "Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism".
    Circulation. 2016;133:e379.
    PubMed     Text format    


  306. NADIR MA
    Letter by Nadir Regarding Article, "Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism".
    Circulation. 2016;133:e378.
    PubMed     Text format    


  307. YANG P, Xu G
    Letter by Yang and Xu Regarding Article, "Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction".
    Circulation. 2016;133:e375.
    PubMed     Text format    


  308. LIPPI G, Cervellin G
    Letter by Lippi and Cervellin Regarding Article, "Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction".
    Circulation. 2016;133:e374.
    PubMed     Text format    


  309. BRADLEY SM, O'Donnell CI, Grunwald GK, Liu CF, et al
    Response to Letter Regarding Article, "Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Re
    Circulation. 2016;133:e377.
    PubMed     Text format    


  310. WASFY JH, Dominici F, Yeh RW
    Letter by Wasfy et al Regarding Article, "Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment,
    Circulation. 2016;133:e376.
    PubMed     Text format    


  311. BHATIA N, Santos M, Jones LW, Beckman JA, et al
    Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer.
    Circulation. 2016;133:537-41.
    PubMed     Text format    


  312. TONELLI M, Karumanchi SA, Thadhani R
    Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Circulation. 2016;133:518-36.
    PubMed     Text format     Abstract available


    January 2016
  313. HOWANGYIN KY, Zlatanova I, Pinto C, Ngkelo A, et al
    Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Co-Ordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor.
    Circulation. 2016 Jan 27. pii: CIRCULATIONAHA.115.020857.
    PubMed     Text format     Abstract available


  314. RIBEIRO AL, Duncan BB, Brant LC, Lotufo PA, et al
    Cardiovascular Health in Brazil: Trends and Perspectives.
    Circulation. 2016;133:422-33.
    PubMed     Text format     Abstract available


  315. MEHTA LS, Beckie TM, DeVon HA, Grines CL, et al
    Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Jan 25. pii: CIR.0000000000000351.
    PubMed     Text format     Abstract available


  316. BLAHA MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, et al
    Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study Of Atherosclerosis (MESA).
    Circulation. 2016 Jan 22. pii: CIRCULATIONAHA.115.018524.
    PubMed     Text format     Abstract available


  317. STUB D, Smith K, Bernard S, Nehme Z, et al
    Response to Letter Regarding Article, "Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction".
    Circulation. 2016;133:e29.
    PubMed     Text format    


  318. BULLUCK H, Hausenloy DJ
    Letter by Bulluck and Hausenloy Regarding Article, "Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction".
    Circulation. 2016;133:e28.
    PubMed     Text format    


  319. SADO DM, Kozor R, Corr L, Moon JC, et al
    Global Myocardial Edema in Antisynthetase Syndrome Detected by Cardiovascular Magnetic Resonance Mapping Techniques.
    Circulation. 2016;133:e25-6.
    PubMed     Text format    


  320. GARCIA LA
    Endovascular Therapy for Femoropopliteal Disease: Drug-Eluting Stents Are Not the Default Therapy.
    Circulation. 2016;133:330-6.
    PubMed     Text format    


  321. BURKET MW
    Drug-Eluting Stents Are the Default Strategy for Superficial Femoral Artery Intervention Now.
    Circulation. 2016;133:320-9.
    PubMed     Text format    


  322. O'DONOGHUE ML, Bhatt DL, Stone GW, Steg PG, et al
    Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.
    Circulation. 2016;133:248-55.
    PubMed     Text format     Abstract available


  323. RYDEN L, Buhlin K, Ekstrand E, de Faire U, et al
    Periodontitis Increases the Risk of a First Myocardial Infarction: A Report From the PAROKRANK Study.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.020324.
    PubMed     Text format     Abstract available


  324. STEWART R, West M
    Increasing Evidence for an Association Between Periodontitis and Cardiovascular Disease.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.020869.
    PubMed     Text format     Abstract available


  325. BASU S, Yudkin JS, Sussman J, Millett C, et al
    Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target-Versus Risk-Based Blood Pressure Treatment.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.019985.
    PubMed     Text format     Abstract available


  326. TANIWAKI M, Radu MD, Zaugg S, Amabile N, et al
    Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
    Circulation. 2016 Jan 13. pii: CIRCULATIONAHA.115.019071.
    PubMed     Text format     Abstract available


  327. RANASINGHE I, Shojaee A, Bikdeli B, Gupta A, et al
    Response to Letter Regarding Article, "Poorly Cited Articles in Peer-Reviewed Cardiovascular Journals from 1997 to 2007: Analysis of 5-Year Citation Rates".
    Circulation. 2016;133:e23-4.
    PubMed     Text format    


  328. SIPIDO KR, Glanzel W
    Letter by Sipido and Glanzel Regarding Article, "Poorly Cited Articles in Peer-Reviewed Cardiovascular Journals from 1997 to 2007: Analysis of 5-Year Citation Rates".
    Circulation. 2016;133:e22.
    PubMed     Text format    


  329. SHAH SH, Arnett D, Houser SR, Ginsburg GS, et al
    Opportunities for the Cardiovascular Community in the Precision Medicine Initiative.
    Circulation. 2016;133:226-31.
    PubMed     Text format     Abstract available


  330. GIDDING SS, Rana JS, Prendergast C, McGill H, et al
    Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score in Young Adults Predicts Coronary Artery and Abdominal Aorta Calcium in Middle Age: The CARDIA Study.
    Circulation. 2016;133:139-46.
    PubMed     Text format     Abstract available


  331. HARSKAMP RE, Alexander JH, Ferguson TB Jr, Hager R, et al
    Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.
    Circulation. 2016;133:131-8.
    PubMed     Text format     Abstract available


  332. MOZAFFARIAN D
    Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review.
    Circulation. 2016 Jan 8. pii: CIRCULATIONAHA.115.018585.
    PubMed     Text format     Abstract available


  333. ADJEDJ J, De Bruyne B, Flore V, Di Gioia G, et al
    Significance of Intermediate Values of Fractional Flow Reserve in Patients with Coronary Artery Disease.
    Circulation. 2016 Jan 5. pii: CIRCULATIONAHA.115.018747.
    PubMed     Text format     Abstract available


    December 2015
  334. HESS CN, Wang TY, McCoy LA, Messenger JC, et al
    Unplanned Inpatient and Observation Rehospitalizations After Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Study.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.017001.
    PubMed     Text format     Abstract available


  335. FIGUEROA JF, Joynt KE
    Unplanned Rehospitalizations and Depression: Time for a New Approach?
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.020528.
    PubMed     Text format     Abstract available


  336. PATEL RS, Ghasemzadeh N, Eapen DJ, Sher S, et al
    A Novel Biomarker of Oxidative Stress is Associated with Risk of Death in Patients with Coronary Artery Disease.
    Circulation. 2015 Dec 16. pii: CIRCULATIONAHA.115.019790.
    PubMed     Text format     Abstract available


  337. CONNELLY KA, Yan AT, Leiter LA, Bhatt DL, et al
    Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus.
    Circulation. 2015;132:2345-50.
    PubMed     Text format    


  338. COLANTONIO LD, Bittner V, Reynolds K, Levitan EB, et al
    Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.
    Circulation. 2015 Dec 9. pii: CIRCULATIONAHA.115.011646.
    PubMed     Text format     Abstract available


  339. WILSON PW
    Changing Cholesterol Levels and Coronary Heart Disease Risk.
    Circulation. 2015 Dec 9. pii: CIRCULATIONAHA.115.020380.
    PubMed     Text format     Abstract available


  340. SABIK JF 3RD
    Should Coronary Artery Bypass Grafting Be Performed in Patients With Moderate Stenosis of the LAD?
    Circulation. 2015 Dec 8. pii: CIRCULATIONAHA.115.020084.
    PubMed     Text format     Abstract available


  341. BELLINGER AM, Arteaga CL, Force T, Humphreys BD, et al
    Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Circulation. 2015;132:2248-58.
    PubMed     Text format     Abstract available


  342. SOTOS-PRIETO M, Bhupathiraju SN, Mattei J, Fung TT, et al
    Changes in Diet Quality Scores and Risk of Cardiovascular Disease Among US Men and Women.
    Circulation. 2015;132:2212-9.
    PubMed     Text format     Abstract available


  343. REGENSTEINER JG, Golden S, Huebschmann AG, Barrett-Connor E, et al
    Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Dec 7. pii: CIR.0000000000000343.
    PubMed     Text format    


  344. TSANG MY, Abudiab MM, Ammash NM, Naqvi TZ, et al
    Quadricuspid Aortic Valve: Characteristics, Associated Structural Cardiovascular Abnormalities, and Clinical Outcomes.
    Circulation. 2015 Dec 3. pii: CIRCULATIONAHA.115.017743.
    PubMed     Text format     Abstract available


  345. MITTEN MJ, Zipes DP, Maron BJ, Bryant WJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Assoc
    Circulation. 2015;132:e346-9.
    PubMed     Text format    


  346. LINK MS, Mark Estes NA 3rd, Maron BJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015;132:e339-42.
    PubMed     Text format    


  347. LINK MS, Myerburg RJ, Estes NA 3rd
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific State
    Circulation. 2015;132:e334-8.
    PubMed     Text format    


  348. ESTES NA 3RD, Kovacs RJ, Baggish AL, Myerburg RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of
    Circulation. 2015;132:e330-3.
    PubMed     Text format    


  349. ZIPES DP, Link MS, Ackerman MJ, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiolog
    Circulation. 2015;132:e315-25.
    PubMed     Text format    


  350. THOMPSON PD, Myerburg RJ, Levine BD, Udelson JE, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Circulation. 2015;132:e310-4.
    PubMed     Text format    


  351. BRAVERMAN AC, Harris KM, Kovacs RJ, Maron BJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of C
    Circulation. 2015;132:e303-9.
    PubMed     Text format    


  352. BLACK HR, Sica D, Ferdinand K, White WB, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Circulation. 2015;132:e298-302.
    PubMed     Text format    


  353. BONOW RO, Nishimura RA, Thompson PD, Udelson JE, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015;132:e292-7.
    PubMed     Text format    


  354. VAN HARE GF, Ackerman MJ, Evangelista JA, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015;132:e281-91.
    PubMed     Text format    


  355. MARON BJ, Udelson JE, Bonow RO, Nishimura RA, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scie
    Circulation. 2015;132:e273-80.
    PubMed     Text format    


  356. LEVINE BD, Baggish AL, Kovacs RJ, Link MS, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American C
    Circulation. 2015;132:e262-6.
    PubMed     Text format    


  357. MARON BJ, Zipes DP, Kovacs RJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiolog
    Circulation. 2015;132:e256-61.
    PubMed     Text format    


    November 2015
  358. SUNG SH, Lu TM, Yeh YC, Lu YW, et al
    Response to Letter Regarding Article, "MacCallum Plaque Causes Acute Myocardial Infarction in a Young Man".
    Circulation. 2015;132:e253.
    PubMed     Text format    


  359. TUNCEZ A, Demir K, Avci A
    Letter by Tuncez et al Regarding Article, "MacCallum Plaque Causes Acute Myocardial Infarction in a Young Man".
    Circulation. 2015;132:e252.
    PubMed     Text format    


  360. GARG P, Abdel-Rahman SE, Greenwood JP, Plein S, et al
    Free-Wall Rupture Post-Reperfused Acute Myocardial Infarction: Insights From Multimodality Cardiovascular Imaging.
    Circulation. 2015;132:e245-7.
    PubMed     Text format    


  361. MEHTA RH, Shahian DM, Sheng S, O'Brien SM, et al
    Association of Hospital and Physician Characteristics and Care Processes with Racial Disparities in Procedural Outcomes Among Contemporary Patients Undergoing Coronary Artery Bypass Grafting Surgery.
    Circulation. 2015 Nov 24. pii: CIRCULATIONAHA.115.015957.
    PubMed     Text format     Abstract available


  362. PIETTE JD, List J, Rana GK, Townsend W, et al
    Mobile Health Devices as Tools for Worldwide Cardiovascular Risk Reduction and Disease Management.
    Circulation. 2015;132:2012-27.
    PubMed     Text format     Abstract available


  363. LICHTENSTEIN AH
    Fruits and Vegetables Get a Golden Halo Once Again: Is There More to the Story?
    Circulation. 2015;132:1946-8.
    PubMed     Text format    


  364. MACRAE CA, Pollak MR
    Effect Size Does Matter: The Long Road to Mechanistic Insight From Genome-Wide Association.
    Circulation. 2015;132:1943-5.
    PubMed     Text format    


  365. LUEPKER RV
    Falling Coronary Heart Disease Rates: A Better Explanation?
    Circulation. 2015 Nov 18. pii: CIRCULATIONAHA.115.019862.
    PubMed     Text format     Abstract available


  366. MANNSVERK J, Wilsgaard T, Mathiesen EB, Lochen ML, et al
    Trends in Modifiable Risk Factors are Associated With Declining Incidence of Hospitalized and Non-Hospitalized Acute Coronary Heart Disease in a Population.
    Circulation. 2015 Nov 18. pii: CIRCULATIONAHA.115.016960.
    PubMed     Text format     Abstract available


  367. TREMMEL JA, Fearon WF, Lee BK, Lim HS, et al
    Response to Letters Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease".
    Circulation. 2015;132:e244.
    PubMed     Text format    


  368. SAVAS G, Kalay N
    Letter by Savas and Kalay Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease".
    Circulation. 2015;132:e243.
    PubMed     Text format    


  369. SHEIKH AR, Zeitz C, Beltrame JF
    Letter by Sheikh et al Regarding Article, "Invasive Evaluation Of Patients With Angina in the Absence of Obstructive Coronary Artery Disease".
    Circulation. 2015;132:e242.
    PubMed     Text format    


  370. DE ARAUJO GONCALVES P, Echavarria-Pinto M, Garcia-Garcia HM
    Letter by de Araujo Goncalves et al Regarding Article, "Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease".
    Circulation. 2015;132:e241.
    PubMed     Text format    


  371. PASUPATHY S, Air T, Dreyer RP, Tavella R, et al
    Response to Letter Regarding Article, "Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries".
    Circulation. 2015;132:e232.
    PubMed     Text format    


  372. MAHAJAN AM, Dugan KE, Reynolds HR
    Letter by Mahajan et al Regarding Article, "Systematic Review of Patients Presenting With Suspected Myocardial Infarction and Nonobstructive Coronary Arteries".
    Circulation. 2015;132:e231.
    PubMed     Text format    


  373. ALEXANDER KP, Weisz G, Prather K, James S, et al
    Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
    Circulation. 2015 Nov 10. pii: CIRCULATIONAHA.115.019768.
    PubMed     Text format     Abstract available


  374. EISENBERG MJ, Windle SB, Roy N, Old W, et al
    Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome.
    Circulation. 2015 Nov 9. pii: CIRCULATIONAHA.115.019634.
    PubMed     Text format     Abstract available


  375. SOARES-MIRANDA L, Siscovick DS, Psaty BM, Longstreth WT Jr, et al
    Physical Activity and Risk of Coronary Heart Disease and Stroke in Older Adults: The Cardiovascular Health Study.
    Circulation. 2015 Nov 4. pii: CIRCULATIONAHA.115.018323.
    PubMed     Text format     Abstract available


  376. PSATY BM, Delaney JA, Arnold AM, Curtis LH, et al
    The Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.
    Circulation. 2015 Nov 4. pii: CIRCULATIONAHA.115.018610.
    PubMed     Text format     Abstract available


  377. TAYLOR AJ
    Cardiovascular Disease: Another Hidden Cost of War?
    Circulation. 2015 Nov 3. pii: CIRCULATIONAHA.115.019327.
    PubMed     Text format     Abstract available


  378. LEE CH, Son JW
    Anomaly of the Descending Aorta: Multifurcation and Reunion.
    Circulation. 2015;132:1745-6.
    PubMed     Text format    


  379. REDDY S, Bernstein D
    Molecular Mechanisms of Right Ventricular Failure.
    Circulation. 2015;132:1734-42.
    PubMed     Text format     Abstract available


  380. ACKERMAN MJ, Zipes DP, Kovacs RJ, Maron BJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015 Nov 2. pii: CIR.0000000000000246.
    PubMed     Text format    


  381. MARON BJ, Harris KM, Thompson PD, Eichner ER, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015 Nov 2. pii: CIR.0000000000000250.
    PubMed     Text format    


  382. MARON BJ, Levine BD, Washington RL, Baggish AL, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart As
    Circulation. 2015 Nov 2. pii: CIR.0000000000000238.
    PubMed     Text format    


    October 2015
  383. MARON BJ, Rowin EJ, Casey SA, Lesser JR, et al
    Hypertrophic Cardiomyopathy in Children, Adolescents and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Circulation. 2015 Oct 30. pii: CIRCULATIONAHA.115.017633.
    PubMed     Text format     Abstract available


  384. GERSTEIN HC, Pare G, McQueen MJ, Haenel H, et al
    Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia.
    Circulation. 2015 Oct 30. pii: CIRCULATIONAHA.115.015744.
    PubMed     Text format     Abstract available


  385. COLIN GC, Vancraeynest D, Hoton D, Jonard P, et al
    Complete heart block caused by diffuse pseudotumoral cardiac involvement in granulomatosis with polyangiitis.
    Circulation. 2015;132:e207-10.
    PubMed     Text format    


  386. KUTYIFA V, Moss AJ, Klein H, Biton Y, et al
    Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Circulation. 2015;132:1613-9.
    PubMed     Text format     Abstract available


  387. WALSH MN
    Risk of Obstructive Sleep Apnea: Sex Matters.
    Circulation. 2015;132:1305-6.
    PubMed     Text format    


    September 2015
  388. BEHNES M, Akin I, Borggrefe M, Traunwieser D, et al
    Response to letter regarding article, "effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis".
    Circulation. 2015;132:e163.
    PubMed     Text format    


  389. SEROPIAN IM, Abbate A
    Letter by Seropian and Abbate regarding article, "effect of tumor necrosis factor inhibitor treatment on proximal right coronary chronic total occlusion in a patient with rheumatoid arthritis".
    Circulation. 2015;132:e162.
    PubMed     Text format    


  390. BOHULA EA, Giugliano RP, Cannon CP, Zhou J, et al
    Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Circulation. 2015;132:1224-33.
    PubMed     Text format     Abstract available


  391. ZHENG Y, Sun JP, Shen X, Qiao Z, et al
    Subepicardial Aneurysm That Was Diagnosed by Cardiac Imaging and Underwent Successful Surgery.
    Circulation. 2015;132:e149-51.
    PubMed     Text format    


  392. ARAKI S, Izumiya Y, Rokutanda T, Ianni A, et al
    Sirt7 Contributes to Myocardial Tissue Repair by Maintaining Transforming Growth Factor-beta Signaling Pathway.
    Circulation. 2015;132:1081-93.
    PubMed     Text format     Abstract available


  393. NABEL EG
    Heart Disease Prevention in Young Women: Sounding an Alarm.
    Circulation. 2015;132:989-91.
    PubMed     Text format    


  394. SOEDA T, Uemura S, Park SJ, Jang Y, et al
    Incidence and Clinical Significance of Poststent Optical Coherence Tomography Findings: One-Year Follow-Up Study From a Multicenter Registry.
    Circulation. 2015;132:1020-9.
    PubMed     Text format     Abstract available


  395. NAJI P, Griffin BP, Sabik JF, Kusunose K, et al
    Characteristics and Outcomes of Patients With Severe Bioprosthetic Aortic Valve Stenosis Undergoing Redo Surgical Aortic Valve Replacement.
    Circulation. 2015 Sep 10. pii: CIRCULATIONAHA.115.015939.
    PubMed     Text format     Abstract available


  396. KREBS-SMITH SM, Subar AF, Reedy J
    Examining Dietary Patterns in Relation to Chronic Disease: Matching Measures and Methods to Questions of Interest.
    Circulation. 2015;132:790-3.
    PubMed     Text format    


    August 2015
  397. QUEREJETA ROCA G, Redline S, Claggett B, Bello N, et al
    Sex-Specific Association of Sleep Apnea Severity with Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study.
    Circulation. 2015 Aug 27. pii: CIRCULATIONAHA.115.016985.
    PubMed     Text format     Abstract available


  398. MIHIC A, Cui Z, Wu J, Vlacic G, et al
    A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and Improves Cardiac Function After Implantation into Myocardial Infarct.
    Circulation. 2015;132:772-84.
    PubMed     Text format     Abstract available


  399. AL-HIJJI M, Yoon Park J, El Sabbagh A, Amin M, et al
    The Forgotten Valve: Isolated Severe Tricuspid Valve Stenosis.
    Circulation. 2015;132:e123-5.
    PubMed     Text format    


  400. AVERSANO T
    Yes, We Can! (Should We?).
    Circulation. 2015;132:365-7.
    PubMed     Text format    


    July 2015
  401. LEWIS TT
    Trauma and Posttraumatic Stress Disorder: Emerging Risk Factors for Cardiovascular Disease in Women?
    Circulation. 2015;132:227-9.
    PubMed     Text format    


  402. ZHU Z, Fu Y, Tian D, Sun N, et al
    Combination of an Immune Modulator Fingolimod with Alteplase in Acute Ischemic Stroke: A Pilot Trial.
    Circulation. 2015 Jul 22. pii: CIRCULATIONAHA.115.016371.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: